Health
Life-extending drug for incurable breast cancer approved for NHS use – The Guardian
About 3,300 women a year may benefit from decision to approve ribociclib
Breast cancerAbout 3,300 women a year may benefit from decision to approve ribociclib
Fri 26 Feb 2021 08.57 EST
Women with incurable advanced breast cancer will be able to get a drug from the NHS that can potentially extend their life by almost eight months, under new guidance.
The National Institute for Health and Care Excellence (Nice) has approved the drug ribociclib , also known as Kisqali for routine use by the NHS in England and Wales. It said around 3,300 women a year with advanced breast…
-
Noosa News22 hours agoUrgent warning to locals as multiple crews battle major industrial fire at Rocklea in Brisbane’s south
-
Noosa News24 hours agoSurfer attacked by Great White shark off northern NSW coast
-
Noosa News22 hours agoDr Vahid Reza Adib gives evidence at first day of inquest into the death of his patient Rosemarie Campbell
-
General24 hours agoCronulla Sharks captain Cameron McInnes to miss remainder of 2025 with second ACL rupture